Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.


Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 1 9 2020
medline: 8 4 2022
entrez: 1 9 2020
Statut: ppublish

Résumé

Treatment of glioblastoma xenografts with chloroquine results in macroautophagy/autophagy inhibition, resulting in a reduction of tumor hypoxia and sensitization to radiation. Preclinical data show that

Identifiants

pubmed: 32866424
doi: 10.1080/15548627.2020.1816343
pmc: PMC8496728
doi:

Substances chimiques

Chloroquine 886U3H6UFF
Temozolomide YF1K15M17Y

Types de publication

Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2604-2612

Références

Autophagy. 2014 Aug;10(8):1359-68
pubmed: 24991840
J Natl Cancer Inst. 2009 May 20;101(10):708-20
pubmed: 19436029
Radiother Oncol. 2009 Sep;92(3):399-404
pubmed: 19616331
Oncol Lett. 2017 Jul;14(1):322-328
pubmed: 28693171
Cancer Chemother Pharmacol. 2017 Nov;80(5):1005-1012
pubmed: 28980060
Cancer Lett. 2015 May 1;360(2):195-204
pubmed: 25681668
Radiother Oncol. 2009 Sep;92(3):411-6
pubmed: 19616335
Front Oncol. 2018 Aug 27;8:335
pubmed: 30211116
J Clin Invest. 2010 Jan;120(1):127-41
pubmed: 20038797
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Eur J Pharmacol. 2016 Jan 15;771:139-44
pubmed: 26687632
Autophagy. 2018;14(2):283-295
pubmed: 29377763
Ann Intern Med. 2006 Mar 7;144(5):337-43
pubmed: 16520474
EMBO J. 2006 Feb 22;25(4):683-92
pubmed: 16467847
Neuro Oncol. 2015 Jun;17(6):776-83
pubmed: 25313193
Cancer Lett. 2015 Mar 28;358(2):220-231
pubmed: 25542083
PLoS One. 2012;7(6):e38706
pubmed: 22745676
J Neurosurg. 2003 Feb;98(2):378-84
pubmed: 12593626
Breast Cancer Res Treat. 2019 Nov;178(2):327-335
pubmed: 31392517
Cell Death Differ. 2005 Nov;12 Suppl 2:1535-41
pubmed: 16247501
Lancet Infect Dis. 2007 Aug;7(8):549-58
pubmed: 17646028
Neuro Oncol. 2014 Oct;16 Suppl 8:viii1-6
pubmed: 25342599
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Cancer Res. 2001 Jan 15;61(2):439-44
pubmed: 11212227
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
J Pharm Pharmacol. 1982 Nov;34(11):733-5
pubmed: 6129306
BMC Neurol. 2016 Sep 20;16(1):178
pubmed: 27644442
Autophagy. 2012 Feb 1;8(2):200-12
pubmed: 22252008
Anticancer Drugs. 2013 Jan;24(1):14-9
pubmed: 23111416
Lancet Oncol. 2017 Jun;18(6):e315-e329
pubmed: 28483413
Strahlenther Onkol. 2014 Oct;190(10):957-61
pubmed: 24928248
Neurosurg Focus. 2014 Dec;37(6):E12
pubmed: 25434381
Ophthalmology. 2011 Feb;118(2):415-22
pubmed: 21292109
Cell Death Differ. 2004 Apr;11(4):448-57
pubmed: 14713959
Nat Med. 2007 Sep;13(9):1050-9
pubmed: 17704786
Cell Death Differ. 2014 Jan;21(1):92-9
pubmed: 24037090
Int J Oncol. 2005 May;26(5):1401-10
pubmed: 15809734
Cancer Biol Ther. 2009 Apr;8(8):730-8
pubmed: 19252415
Mol Biol Cell. 2004 Mar;15(3):1101-11
pubmed: 14699058
Ther Drug Monit. 1989;11(4):369-79
pubmed: 2662478
PLoS One. 2012;7(10):e47357
pubmed: 23091617
Cancer Res. 2003 Oct 15;63(20):6962-70
pubmed: 14583498
Cancer Cell. 2014 Aug 11;26(2):190-206
pubmed: 25117709
Oncoimmunology. 2014 Jul 03;3(7):e944047
pubmed: 25610726
Surg Neurol. 2007 Apr;67(4):388-91
pubmed: 17350410
Cell Death Dis. 2013 Oct 10;4:e838
pubmed: 24113172
J Neurooncol. 2015 Mar;122(1):11-20
pubmed: 25528635
Eur J Clin Pharmacol. 1992;42(4):429-33
pubmed: 1307690
Radiother Oncol. 2007 Jun;83(3):333-9
pubmed: 17512071
Drug Resist Updat. 2004 Feb;7(1):25-40
pubmed: 15072769
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931

Auteurs

Inge Compter (I)

Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Danielle B P Eekers (DBP)

Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Ann Hoeben (A)

Department of Medical Oncology, GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Kasper M A Rouschop (KMA)

Department of Radiotherapy, GROW School for Oncology, Maastricht University, Maastricht, The Netherlands.

Bart Reymen (B)

Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Linda Ackermans (L)

Department of Neurosurgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Jan Beckervordersantforth (J)

Department of Pathology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Noel J C Bauer (NJC)

Department of Ophthalmology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Monique M Anten (MM)

Department of Neurology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Pieter Wesseling (P)

Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Alida A Postma (AA)

Department of Radiology and Nuclear Medicine, School for Mental Health and Sciences, Maastricht University Medical Centre+, Maastricht University Medical Center, Maastricht, The Netherlands.

Dirk De Ruysscher (D)

Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Philippe Lambin (P)

Department of Radiology and Nuclear Medicine, School for Mental Health and Sciences, Maastricht University Medical Centre+, Maastricht University Medical Center, Maastricht, The Netherlands.
The D-Lab & the M-lab, Dpt of Precision Medicine, GROW - School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH